Daily Mail6 Nov 2018 07:18
Specialist pharmaceutical company N4 Pharma (N4P), which is developing ways to deliver vaccines and cancer treatments to cells in the body, rocketed as it extended a research partnership. N4 has been working with Medimmune to develop nanoparticle medicines, as part of a Government-funded project. This ended last week, but the firms are now signing a collaboration agreement to allow their work to continue.